Targeting metabolism to regulate immune responses in autoimmunity and cancer
- PMID: 31363227
- DOI: 10.1038/s41573-019-0032-5
Targeting metabolism to regulate immune responses in autoimmunity and cancer
Abstract
Metabolic programming is emerging as a critical mechanism to alter immune cell activation, differentiation and function. Targeting metabolism does not completely suppress or activate the immune system but selectively regulates immune responses. The different metabolic requirements of the diverse cells that constitute an immune response provide a unique opportunity to separate effector functions from regulatory functions. Likewise, cells can be metabolically reprogrammed to promote either their short-term effector functions or long-term memory capacity. Studies in the growing field of immunometabolism support a paradigm of 'cellular selectivity based on demand', in which generic inhibitors of ubiquitous metabolic processes selectively affect cells with the greatest metabolic demand and have few effects on other cells of the body. Targeting metabolism, rather than particular cell types or cytokines, in metabolically demanding processes such as autoimmunity, graft rejection, cancer and uncontrolled inflammation could lead to successful strategies in controlling the pathogenesis of these complex disorders.
Similar articles
-
Targeting T cell metabolism to regulate T cell activation, differentiation and function in disease.Curr Opin Immunol. 2017 Jun;46:82-88. doi: 10.1016/j.coi.2017.04.006. Epub 2017 May 15. Curr Opin Immunol. 2017. PMID: 28521236 Free PMC article. Review.
-
Metabolic regulation of pathogenic autoimmunity: therapeutic targeting.Curr Opin Immunol. 2019 Dec;61:10-16. doi: 10.1016/j.coi.2019.07.001. Epub 2019 Aug 15. Curr Opin Immunol. 2019. PMID: 31422315 Free PMC article. Review.
-
Therapies Targeting Trained Immune Cells in Inflammatory and Autoimmune Diseases.Front Immunol. 2021 Jan 25;11:631743. doi: 10.3389/fimmu.2020.631743. eCollection 2020. Front Immunol. 2021. PMID: 33569065 Free PMC article. Review.
-
Metabolic control of immune tolerance in health and autoimmunity.Semin Immunol. 2016 Oct;28(5):491-504. doi: 10.1016/j.smim.2016.09.006. Epub 2016 Oct 5. Semin Immunol. 2016. PMID: 27720234 Review.
-
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions.Signal Transduct Target Ther. 2024 Oct 9;9(1):268. doi: 10.1038/s41392-024-01954-6. Signal Transduct Target Ther. 2024. PMID: 39379377 Free PMC article. Review.
Cited by
-
Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies.Acta Pharm Sin B. 2021 May;11(5):1158-1174. doi: 10.1016/j.apsb.2021.03.013. Epub 2021 Mar 12. Acta Pharm Sin B. 2021. PMID: 34094826 Free PMC article. Review.
-
Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity In Vivo.Mol Ther Methods Clin Dev. 2020 Jun 1;18:652-663. doi: 10.1016/j.omtm.2020.05.025. eCollection 2020 Sep 11. Mol Ther Methods Clin Dev. 2020. PMID: 32802913 Free PMC article.
-
Controlling Herpes Simplex Virus-Induced Immunoinflammatory Lesions Using Metabolic Therapy: a Comparison of 2-Deoxy-d-Glucose with Metformin.J Virol. 2022 Jul 27;96(14):e0068822. doi: 10.1128/jvi.00688-22. Epub 2022 Jul 11. J Virol. 2022. PMID: 35862706 Free PMC article.
-
Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.Mol Cancer. 2022 Jan 21;21(1):27. doi: 10.1186/s12943-021-01486-5. Mol Cancer. 2022. PMID: 35062950 Free PMC article. Review.
-
Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.J Transl Med. 2021 Jun 30;19(1):279. doi: 10.1186/s12967-021-02952-w. J Transl Med. 2021. PMID: 34193202 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical